cabozantinib and Carcinoma--Squamous-Cell

cabozantinib has been researched along with Carcinoma--Squamous-Cell* in 2 studies

Other Studies

2 other study(ies) available for cabozantinib and Carcinoma--Squamous-Cell

ArticleYear
Low-dose nivolumab and cabozantinib in recurrent intestinal-type papillary adenocarcinoma of the sinonasal region.
    BMJ case reports, 2023, Nov-03, Volume: 16, Issue:11

    Intestinal-type sinonasal adenocarcinoma is a rare epithelial malignancy primarily treated with surgery and chemoradiation. The combination of low-dose immunotherapy and a tyrosine kinase inhibitor in recurrent disease has not been previously studied.A man in his 20s with papillary adenocarcinoma of the sinonasal region, following surgical resection, was treated with six cycles of concurrent chemoradiotherapy, followed by four cycles of docetaxel, cisplatin and capecitabine. While on treatment, he was found to have extensive residual disease and he was started on low-dose nivolumab and cabozantinib. Repeat imaging after ten months of treatment revealed a significant reduction in lesions.Non-squamous head and neck cancers are often excluded from major trials, and the effect of immunotherapy in these histologies is poorly understood. The response seen with low-dose immunotherapy underscores the need for further research in this setting.

    Topics: Adenocarcinoma; Adenocarcinoma, Papillary; Adult; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Chemoradiotherapy; Cisplatin; Head and Neck Neoplasms; Humans; Male; Nivolumab

2023
A Constitutional Activating
    Clinical cancer research : an official journal of the American Association for Cancer Research, 2019, 07-15, Volume: 25, Issue:14

    The genesis of all cancers results from an accumulation of mutations, constitutional and/or acquired when induced by external mutagenic factors. High-speed technologies for genome sequencing have completely changed the study of disease genetics, but with limited knowledge of the functional value of most genetic changes.. Here, we proposed an innovative individual approach by studying tissue samples from a young woman with an unusual association of breast cancer, polycythemia vera, and rheumatoid arthritis. We performed genomic analyses for copy number variations and point mutations on laser-microdissected tumor cells from the breast cancer, and on CD34. Using ONCOSCAN technology, we identified a constitutional pR988C, c2962C>T mutation of. Our study opens a considerable field of application in the domain of constitutional genetics, to establish genetic links between cancers and other very different severe diseases.

    Topics: Adult; Anilides; Animals; Arthritis, Rheumatoid; Autoimmune Diseases; Breast Neoplasms; Carcinoma, Squamous Cell; Chronic Disease; Female; Humans; Mice; Mice, Inbred C57BL; Mice, Transgenic; Mutation; Myeloproliferative Disorders; Polycythemia Vera; Proto-Oncogene Proteins c-met; Pyridines; Skin Neoplasms

2019